New depression treatment enters next safety check
Disease control
ENROLLING_BY_INVITATION
This study continues testing an experimental medication called SPT-300 for adults with major depression. It follows 360 people who completed a previous trial to gather more safety information over 6 weeks. The main goal is to see how well people tolerate the drug and monitor for …
Phase: PHASE2 • Sponsor: Seaport Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC